Insulet Stock Debt To Equity
| GOV Stock | EUR 254.10 2.10 0.83% |
Insulet fundamentals help investors to digest information that contributes to Insulet's financial success or failures. It also enables traders to predict the movement of Insulet Stock. The fundamental analysis module provides a way to measure Insulet's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Insulet stock.
Insulet |
Insulet Company Debt To Equity Analysis
Insulet's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Insulet Debt To Equity | 272.60 % |
Most of Insulet's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Insulet is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, Insulet has a Debt To Equity of 272%. This is much higher than that of the Healthcare sector and notably higher than that of the Medical Devices industry. The debt to equity for all Germany stocks is notably lower than that of the firm.
Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Insulet Fundamentals
| Return On Equity | 0.0089 | |||
| Return On Asset | 0.0183 | |||
| Profit Margin | 0 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 20.54 B | |||
| Shares Outstanding | 69.54 M | |||
| Shares Owned By Insiders | 0.45 % | |||
| Shares Owned By Institutions | 99.54 % | |||
| Price To Earning | 500.89 X | |||
| Price To Book | 49.00 X | |||
| Price To Sales | 16.40 X | |||
| Revenue | 1.31 B | |||
| Gross Profit | 805.6 M | |||
| EBITDA | 36.5 M | |||
| Net Income | 4.6 M | |||
| Cash And Equivalents | 316.37 M | |||
| Cash Per Share | 5.30 X | |||
| Total Debt | 1.37 B | |||
| Debt To Equity | 272.60 % | |||
| Current Ratio | 4.36 X | |||
| Book Value Per Share | 6.85 X | |||
| Cash Flow From Operations | (68.1 M) | |||
| Earnings Per Share | 0.22 X | |||
| Price To Earnings To Growth | 3.32 X | |||
| Target Price | 290.41 | |||
| Number Of Employees | 2.6 K | |||
| Beta | 0.74 | |||
| Market Capitalization | 18.08 B | |||
| Total Asset | 2.25 B | |||
| Z Score | 7.8 | |||
| Net Asset | 2.25 B |
About Insulet Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Insulet's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Insulet using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Insulet based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Insulet Stock
When determining whether Insulet is a strong investment it is important to analyze Insulet's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insulet's future performance. For an informed investment choice regarding Insulet Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Insulet Stock please use our How to Invest in Insulet guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.